Medically reviewed by Doru Paul, MD Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how genetics can affect the success of venetoclax, ...

Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

Paul Mancini had his first hint that something might be wrong when he felt a sharp pain on one side of his chest in the ...

It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma. More therapies are being developed, to the point where somebody diagnosed now is likely to have ...

Sanchez participated in a panel discussion on best practices in multiple myeloma care at a recent Institute for Value-Based Medicine ® event in Chicago. What role does patient education play in ...

Researchers sought to determine whether PRD monitoring would be a suitable replacement for MRD in multiple myeloma.

Biotech HaemaLogiX – which counts former health minister Greg Hunt as a director – is preparing a 2025 ASX listing, as it ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how genetics can affect the success of venetoclax, ...

William Blair analyst Matt Phipps has estimated that there are around 3,000 multiple myeloma patients in the ... company's heritage of innovation in blood cancers and transform patients' lives ...